<DOC>
	<DOCNO>NCT00678301</DOCNO>
	<brief_summary>The purpose study assess immunogenicity term antibody response safety/reactogenicity term solicit unsolicited symptom serious adverse event follow primary vaccination African Sub-Saharan infant pneumococcal conjugate vaccine GSK 1024850A co-administered diphtheria , tetanus , whole cell pertussis ( DTPw ) -combined vaccine oral polio vaccine child first 4 month life .</brief_summary>
	<brief_title>Primary Vaccination Course Children Receiving Pneumococcal Vaccine GSK 1024850A , Zilbrix™ Hib Polio Sabin™</brief_title>
	<detailed_description>Vaccination course 6 , 10 , 14 week age .</detailed_description>
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male female subject , include 610 week age time first vaccination . Subjects investigator believe parent ( ) /guardian ( ) comply requirement protocol enrol study . Written oral , sign thumbprinted informed consent obtain parent ( ) /guardian ( ) child/ward . Where parent ( ) /guardian ( ) illiterate , consent form countersign witness . Free know suspected health problem ( establish medical history clinical examination enter study ) , would contraindicate initiation routine immunization outside clinical trial context . Use investigational nonregistered product ( drug vaccine ) study vaccine within 30 day precede first dose study vaccine , plan use study period . Concurrently participate another clinical study , time study period , subject expose investigational noninvestigational product ( pharmaceutical product device ) . Chronic administration immunosuppressant immunemodifying drug since birth . A family history congenital hereditary immunodeficiency . Any confirm suspected immunosuppressive immunodeficient condition base medical history physical examination . Administration immunoglobulins and/or blood product since birth plan administration study period ( Hepatitis B immunoglobulins birth allow ) . Previous vaccination , diphtheria , tetanus , pertussis , Haemophilus influenzae type b and/or Streptococcus pneumoniae . History , intercurrent diphtheria , tetanus , pertussis , hepatitis B , Streptococcus Haemophilus influenzae type b disease . History allergic disease reaction likely exacerbate component vaccine . History neurological disorder seizure . Major congenital defect serious chronic illness . Acute disease time enrolment . Study entry delayed illness improve . Babies birth weight &lt; 2 kilogram ( know ) Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>pneumococcal conjugate vaccine</keyword>
	<keyword>Streptococcus pneumoniae</keyword>
</DOC>